RYR1 and hepatocellular carcinoma: RYR1 gene mutations are frequently found in both mouse and human NASH-HCC, indicating dysregulation of calcium signaling in cholesterol-related NASH-HCC and NASH rather than steatosis (Liang et al., 2018).